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ABSTRACT  
Adenosine triphosphate (ATP) is a universal source of energy for all living organisms. It 
plays a fundamental intracellular and extracellular role in regulation of cellular metabolism, 
cell signal pathways and biochemical reaction. Its fundamental research and 
diverging application developed really fast, especially after the discovery of ATP aptamer. 
With a great development, the ATP aptamer has been applied to a wide range of area, such 
as biosensor, biomarker and some other detection. In view of the flexibility and versatile 
sequence and structure of nucleic acid, aptamer technology can be used at almost 
everywhere and its advantage is also striking, in lots of aspects even better than the antibody. 
At the same time, rolling circle amplification is in great booming, which can be utilized to 
rapidly copy multiple of DNA sequence by a circular DNA. Its repeated nucleic acid 
sequence, provide a really good vector for ATP aptamer in application. In my experiment, 
we produce a RCA-dependent ATP aptamer-incorporated DNA hydrogel to measure the 
amount of ATP that can be captured by DNA hydrogel. 
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CHAPTER 1 
INTRODUCTION 
1.1 Problem Statement 
Adenosine triphosphate (ATP) is a universal source of energy for all living organisms. It 
plays a fundamental intracellular role in regulation of cellular metabolism and cell signal 
pathways inside the cell. It has been used as an indicator for cell development and cell 
injury (Wang, 2005). In addition, it is also an important extracellular messenger in neural 
tissues (Brake, 1994). It can bind and activate several cell-surface receptors, such as ion 
channels receptor, G-protein-coupled receptors to control many sorts of cellular 
biochemical reactions respectively (Burnstock, 1990). In view of its significant role inside 
cell, it attracted intense interest. Investigators started to use different kinds of methods to 
get various aspects of information on ATP. Cross, R. L figured out the variation on the 
mechanism of ATP formation by using FI-ATPases (Cross, 1981), which leads the straight 
study into the ATP hydrolysis reaction. A few years later, two groups of researchers 
(Ellington, 1990) used their in-vitro selection and amplification to successfully isolate 
certain RNA sequences that could specifically bind to some target molecules, from pools 
of random-sequence libraries (Tuerk, 1990). These kinds of sequence were termed RNA-
binding aptamer. Later, the DNA-binding aptamer were also found (Ellington, 1992). With 
further study, researchers found that DNA/RNA aptamers can be identified as binding to a 
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wide range of targets, and ATP is one of them (Sassanfar, 1993). What’s more, a part of 
aptamers possess high affinity for targets, which due to their flexible mechanism of folding 
in the process. Since the discovery of aptamer-based technology, nucleic acid aptamers 
have frequently been used in biosensor (Navani, 2006 & Cho, 2005), detection (Zheng, 
2009) and new idea development in pharmacology (Chou, 2005). This gives investigators 
a great inspiration and possibility to master ATP. By polymerase chain reaction (PCR) or 
quantitative polymerase chain reaction amplification, an APT-aptamer-based DNA 
solution can be used to capture and transfer non-quantitative or quantitative ATP, but the 
sensitivity of this method so far doesn’t meet the requirement for further development.  
 
1.2 Solutions 
In the mid-1990s, some researchers found an exciting phenomenon that a short single-
stranded DNA (ssDNA) ligated to a circular ssDNA template was constantly elongated by 
some special DNA polymerase (Rubin, 1995 & Liu, 1996). The product of this reaction are 
long linear ssDNA duplexes with considerable repetitive sequence, which is 
complementary to the circular ssDNA template. This method of replication referred to as 
rolling circle amplification (RCA) (Figure 1). Comparing with other conventional methods 
used for nucleic acid amplification, such as PCR, RCA has its own attractive features. For 
example, RCA uses a unique isothermal DNA polymerase, which can catalyzes DNA 
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polymerization at a relatively low and constant temperature. It will reduce the requirement 
for the instrumentations and no longer need the thermally stable DNA polymerase. Also it 
does not require a specific primer because any primer complementary to circular template 
works in RCA. So by using RCA, it can provide thousands-fold amplification in the 
intensity of the outlet signal and finally improve the detection sensitivity (Cheglakov, 2007), 
which can exactly solve the problem of low sensitivity in conventional ATP-aptamer-based 
DNA molecules.  
 
Figure 1. Rolling Circle Amplification, A) after annealing, strand P hybridized strand T. Taq ligase 
can be used to make a circular DNA strands. B) Strand P as a primer to initialize the amplification 
and finally with the help of Phi29 DNA polymerase, multiple of linear ssDNA will be produced 
(Stefan, 2005) 
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However, even we can make an ATP-binding aptamer-incorporated DNA solution system 
which can successfully capture and store ATP, the bulk state of solution will be 
a serious constraint for its further development. So after comparing with other kinds of 
morphologies, the DNA hydrogel seems to be the best choice. DNA hydrogel has a higher 
density and greater compressibility than the ones in solution, so it is more convenient for 
transportation. And in view of its unique feature, DNA hydrogel can create an anisotropic 
environment in solution, which is the solution unable to do. Last but not least, substrate, 
such as drug, can diffuse at a unique velocity in liquid environment. This is a point which 
must be taken into account in pharmaceutical or some other related areas.  
In summary, I designed a special DNA sequence, named T2-ATP, which contains an ATP-
binding aptamer and a complementary region which can be used in the formation of DNA 
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hydrogel (Figure 2, a). In addition, I also design another DNA sequence, named T2, which 
contains a same complementary region as T2-ATP, but it doesn’t have an ATP-binding 
aptamer (Figure 2, b). It plays as a control group in whole project. Takeing all kinds of 
things into account, our RCA-dependent ATP-binding aptamer-incorporated DNA 
hydrogel is a really good choice for the ATP capturing. 
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Figure 2, a) Secondary structure of T2-ATP; b) Secondary structure of T2; c) 
Schematic diagram of formation of RCA-dependent DNA hydrogel  
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1.3 Overall Objectives 
1. To form a DNA hydrogel by using RCA with specific sequences of linear DNA 
templates. 
2. To determine the ATP capturing capacity of the ATP-binding aptamer-incorporated 
DNA hydrogel in a laboratory environment. 
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CHAPRT 2 
LITERATURE REVIEW 
 
2.1 ATP aptamer 
Nucleic acid aptamers are single-stranded oligonucleotides which can bind to their cognate 
targets with high affinities and specificities. It has been over 24 years since two groups of 
researchers (Ellington & Szostak, 1990) used their in-vitro selection and amplification to 
first successfully isolate certain RNA sequences, which is now called RNA aptamers, from 
pools of random-sequence libraries (Tuerk, 1990). Later, the DNA-binding aptamer were 
also found (Ellington, 1992). With further study, researchers have found a broad range of 
targets of DNA/RNA aptamers from small molecules to proteins, and a lot of aptamers 
have been selected as therapeutic target for therapeutic interests, like IgE, E2F transcription 
factor and protein tyrosine kinase 7. Since it appeared, it has been thought to resemble 
antibody due to its high affinity and specificity. While in some respects, aptamer even 
seems to be better and more effective than antibody. For example, the flexible dynamics of 
sequence in aptamer enables it to target virtually all molecules and it can undergo the 
amplification to improve its sensitivity (Iliuk, 2011). Given all the advantages of aptamers, 
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they have frequently been used in biosensor (Navani, 2006 & Cho, 2005), detection (Zheng, 
2009), bio-imaging (Zhang, 2010) and drug discovery (Ireson, 2006 & Chou, 2005). ATP 
detection is also one of the important applications and now several sequences and structures 
of ATP aptamers have been found (figure 2.).  This gives investigators a great inspiration 
and possibility to master ATP. 
 
 
2.2 Rolling Circle Amplification 
Rolling circle amplification (RNA) is a high-efficiency nucleic acid replication which can 
rapidly synthesize multiply copies of ssDNA sequence. Up to 105 tandemly repeats of the 
complementary sequence of circle template will appear in the product sequence. It was first 
found in the mid-1990s (Rubin, 1995 & Liu, 1996). Comparing with other 
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conventional methods used for nucleic acid amplification, such as PCR, RCA has its own 
attractive features. For example, RCA uses a unique isothermal DNA polymerase, which 
can catalyzes DNA polymerization at a relatively low and constant temperature. It will 
reduce the requirement for the instrumentations and no longer need the thermally stable 
DNA polymerase. Also it does not require a specific primer because any primer 
complementary to circular template works in RCA. RCA can provide thousands-fold 
amplification in the intensity of the outlet signal and finally improve the detection 
sensitivity (Cheglakov, 2007). Considering so many advantages over the traditional tool, it 
is not too hard to understand why it quickly gained the attention for majority of researchers 
as soon as the technology is invented. And it can also exactly solve the problem of low 
sensitivity in conventional ATP-aptamer-based DNA molecules, which is invaluable in my 
project. 
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CHARPTER 3 
3.1 Abstract 
Adenosine triphosphate (ATP) is a universal source of energy for all living organisms. It 
plays a fundamental intracellular and extracellular role in regulation of cellular metabolism, 
cell signal pathways and biochemical reaction. Its fundamental research and 
diverging application developed really fast, especially after the discovery of ATP aptamer. 
With a great development, the ATP aptamer has been applied to a wide range of area, such 
as biosensor, biomarker and some other detection. In view of the flexibility and versatile 
sequence and structure of nucleic acid, aptamer technology can be used at almost 
everywhere and its advantage is also striking, in lots of aspects even better than the antibody. 
At the same time, rolling circle amplification is in great booming, which can be utilized to 
rapidly copy multiple of DNA sequence by a circular DNA. Its repeated nucleic acid 
sequence, provide a really good vector for ATP aptamer in application. In my experiment, 
we produce a RCA-dependent ATP aptamer-incorporated DNA hydrogel to measure the 
amount of ATP that can be captured by DNA hydrogel. 
3.2 Materials and Methods 
3.2.1 RCA-based DNA Hydrogel 
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The sequence of T2-ATP: 5’-CGAAGGTGGTCAAATAATCGAGCCTTCCTCCGCAA 
TACTCCCCCAGGCTCGTTTATTCGCTTTGGACG-3’;   
The sequence of T2: 5’- CGAAGGTGGTCAAATAATCGAGCCTGTTTTCAGGCTCG 
TTTATTCGCTTTGGACG-3’;       
The sequence of T1C: 5’- GACCACCTTCGCGTCCAAAGC-3’. 
a) Annealing 
The original concentrations of T2-ATP, T2 and T1C are 379.5μM, 393.01μM and 
354.94μM, respectively. Diluted them to 100μM each by distilled water. Then diluted 
them to 2μM solution (50μl scale) each as the following recipe:  
 10×Taq ligase Buffer(New England Biolabs)    5μl 
 Sample            1μl 
 Distilled Water          44μl 
Anneal the 2μM solution from 95℃ to 20℃ with -1℃ per minute by C1000 TouchTM 
thermal cycler. 
b) Ligation  
Take the T2-ATP, T2 and T1C out of the thermal cycler. Vortex and slightly centrifuge to 
make sure the solution are uniform. Then add the solution as the following recipe: 
 T2 or T2-ATP (after annealing)      5μl 
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 T1C (after annealing)        5μl 
 10×Taq ligase Buffer (New England Biolabs)    1μl 
 Distilled Water          8.5μl 
 Taq ligase (New England Biolabs)     0.5μl 
Before adding the Taq ligase, vortex and slightly centrifuge the tubes to make sure the 
solution mixes well. No vortex and centrifuge allowed after adding Taq ligase. Otherwise, 
the Taq ligase will decrease its activity or even denature. Besides, during the whole process, 
Taq ligase must be kept in ice-bath. After add all solution, put all tubes in 45℃ 
environment and incubate for 18 hours. 
c) Polymerization 
Take the T2-ATP and T2 out of the thermal cycler. Vortex and slightly centrifuge. Then add 
the solution as the following order: 
 
Table 1. DNA hydrogel Preparation for 24 wells in 96-well plate 
Type Capture Capture Release Release 
No. A1-A3 A4-A6 A7-A9 A10-A12 
Gel (50μl) T2 T2-ATP 
T2 growth with 
ATP 
T2 growth with 
ATP (half conc.) 
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Type Release Release Release Release 
No. B1-B3 B4-B6 B7-B9 B10-B12 
Gel (50μl) 
T2-ATP growth 
with ATP 
T2-ATP growth 
with ATP (half 
conc.) 
T2 T2-ATP 
 
Recipe for all above wells: 
No. A1-A6 & B7-B12: 
 Sample           10.0μl 
 10× Phi 29 DNA polymerase Buffer (LucigenTM) 4.0μl 
 Distilled Water         28.5μl 
 dNTP 100mM (New England Biolabs)    5.0μl 
(Vortex and slightly centrifuge) 
 Inorganic pyrophosphatase (New England Biolabs)  2.0μl 
 Phi 29 DNA polymerase       0.5μl 
No. A7-A9 & B1-B3: 
 Sample           10.0μl 
 10× Phi 29 DNA polymerase Buffer (LucigenTM) 4.0μl 
 1mM ATP          2.5μl 
 Distilled Water         26.0μl 
 dNTP 100mM (New England Biolabs)    5.0μl 
(Vortex and slightly centrifuge) 
 Inorganic pyrophosphatase (New England Biolabs)  2.0μl 
 Phi 29 DNA polymerase        0.5μl 
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No. A10-A12 & B4-B6 
 Sample           10.0μl 
 10× Phi 29 DNA polymerase Buffer (LucigenTM) 4.0μl 
 1mM ATP          1.25μl 
 Distilled Water         27.25μl 
 dNTP 100mM (New England Biolabs)    5.0μl 
(Vortex and slightly centrifuge) 
 Inorganic pyrophosphatase (New England Biolabs)  2.0μl 
 Phi 29 DNA polymerase        0.5μl 
After adding all the samples, sealed the 96-well plate by parafilm and place the 96-well 
plate at 30℃ in hybridization oven for 2 days.  
3.2.2 ATP measurement 
In my project, I used the ATP quantitative kit, which contains Luciferase, to measure 
the concentration of ATP. Luciferase is a kind of oxidative enzyme that can interact 
with ATP to produce Luciferyl adenylate, which can keep interacting with O2 to emit 
light. The light intensity is positively related to the concentration in solution in 
theory. So after adding ATP quantitative buffer, put the 96-well plate into plate 
reader. Then we can get the concentration from the light intensity. 
a) ATP standard measurement  
Before doing the ATP measurement, we must get the concentration of Luciferase, by which 
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it is best for the ATP measurement in current concentration. And the result coming from 
the ATP standard measurement can also be a standard to calculate the concentration of ATP 
in solution from the light intensity. 
From the manufactory, when the concentration of ATP is 1mM, the best dilution rate of 
Luciferase is around 1/100. So we try the dilution rate, 1/100, 1/200 and 1/300 to do the 
ATP standard measurement. 
Table 2. Distribution of ATP standard measurement 
Name  1/100 1/200 1/300 
1/100 
with half 
conc of 
ATP. 
1/200 
with half 
conc of 
ATP. 
1/300 
with half 
conc of 
ATP. 
Control 
No. A1, A2 A3, A4 A5, A6 A7, A8 A9, A10 A11, A12 B1, B2 
ATP q kit 1/100 1/200 1/300 1/100 1/200 1/300 0 
ATP 
solution 
2.5μl 
ATP/50μl 
solution 
2.5μl 
ATP/50μl 
solution 
2.5μl 
ATP/50μl 
solution 
1.25μl 
ATP/50μl 
solution 
1.25μl 
ATP/50μl 
solution 
1.25μl 
ATP/50μl 
solution 
2.5μl 
ATP/50μl 
solution 
i. Prepare ATP solution (50μl each) 
 2.5μl ATP/50μl solution 
 Distilled Water         42.5μl 
 10× Phi 29 DNA polymerase Buffer (LucigenTM) 4.0μl 
 10× Taq ligase Buffer (New England Biolabs)  1.0μl 
 ATP 1mM           2.5μl 
 1.25μl ATP/50μl solution 
 Distilled Water         43.75μl 
 10× Phi 29 DNA polymerase Buffer (LucigenTM) 4.0μl 
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 10× Taq ligase Buffer (New England Biolabs)  1.0μl 
 ATP 1mM           1.25μl 
Add ATP solution to the 96-well plate first, respectively. Then prepare the additional 
solution 
ii. Add additional solution (50μl each) 
 Distilled Water   45μl 
 ATP quantitative Buffer  5μl 
iii. Add ATP quantitative kit (100μl each) 
In view of its high sensitivity, we choose to make the ATP quantitative kit at once and then 
divide into aliquot. 
 1/100 ATP quantitative kit 
 Distilled Water        89μl 
 ATP quantitative Buffer    10μl 
 ATP quantitative kit     1μl 
 1/200 ATP quantitative kit 
 1/100 ATP quantitative Buffer  50μl 
 ATP quantitative Buffer    5μl 
 Distilled Water      45μl 
 1/300 ATP quantitative kit 
 1/100 ATP quantitative Buffer   33.3μl 
 ATP quantitative Buffer    6.7μl 
 Distilled Water       60μl 
After the ATP quantitative kit is made, add them into 96-well plate quickly. The whole 
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process keep the ATP quantitative kit away from light and avoid the formation in 96-well 
plate. 
b) ATP measurement 
From the ATP standard measurement, we get the 1/100 dilution of ATP quantitative kit is 
best for the ATP measurement in 1mM group. So we use the 1/100 dilution of ATP 
quantitative kit for this measurement. 
i. Prepare ATP solution for standards 
 2.5μl ATP/50μl solution 
 Distilled Water         42.5μl 
 10× Phi 29 DNA polymerase Buffer (LucigenTM) 4.0μl 
 10× Taq ligase Buffer (New England Biolabs)  1.0μl 
 ATP 1mM           2.5μl 
 1.25μl ATP/50μl solution 
 Distilled Water         43.75μl 
 10× Phi 29 DNA polymerase Buffer (LucigenTM) 4.0μl 
 10× Taq ligase Buffer (New England Biolabs)  1.0μl 
 ATP 1mM           1.25μl 
 Zero  
 Distilled Water         45μl 
 10× Phi 29 DNA polymerase Buffer (LucigenTM) 4.0μl 
 10× Taq ligase Buffer (New England Biolabs)  1.0μl 
 ATP 1mM           0μl 
Put the ATP solution into 96-well plate as following order first, 
C1-C3 with 2.5μl ATP/50μl solution, C4-C6 with 1.25μl ATP/50μl solution, C7-C9 with 
zero. 
ii. Prepare post-add solution 
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 A1-A6 with ATP: 
 Distilled Water      42.5μl 
 ATP 1mM       2.5μl 
 10×ATP quantitative Buffer  5.0μl 
 A7-C9 without ATP: 
 Distilled Water      45.0μl 
 10×ATP quantitative Buffer  5.0μl 
iii. Prepare ATP quantitative kit (100μl each) 
 1/100 dilution of ATP quantitative kit 
 Distilled Water      89μl 
 ATP quantitative Buffer    10μl 
 ATP quantitative kit    1μl 
Add ATP quantitative kit to each well and do the measurement by plate reader quickly. 
The above section is the first trial with 1mM ATP and 1/100 dilution of ATP quantitative 
kit. Then we also do a second trial with 100μM ATP and 1/10 dilution of ATP quantitative 
kit.  
3.3 Results 
a) The first trial with1mM ATP and 1/100 dilution of ATP quantitative kit: 
i. Standard measurement 
The 1/100 dilution of ATP quantitative kit group has the highest light intensity and the 
average value of A1 & A2 is almost twice the one in A7& A8, which use half concentration 
of ATP. And it has the most obvious difference between the ones in two kinds of 
concentration. Though the other two groups seem not so bad, but the light intensity is much 
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smaller which indicates a worse sensitivity.  
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Figure 4. A, B & C show the relationship between light intensity and time in 1/100, 1/200 & 
1/300 ATP q kit dilution group  
ii. ATP measurement 
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Figure 5. A shows in ATP capture assay, the relationship of concentration of ATP left in the upper 
solution with time; B & C they show the concentration of ATP diffused to the upper solution after 
interacting with gel 
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In the T2 & T2-ATP gel in capture assay, the light intensity coming from the interaction 
of ATP left in solution and Luciferase indicates that the concentrations of ATP in T2 & 
T2-ATP gel are almost the same. From the ATP release assay, the amount of ATP which 
diffuse to the upper solution after interaction with DNA hydrogel are still the same 
between T2 and T2-ATP gel. So from the 1mM ATP assay, we cannot find any evidence 
to show T2-ATP gel which contained ATP-aptamer can successfully capture ATP 
molecules. 
b) The second trial with 100μM ATP and 1/10 dilution of ATP quantitative kit.  
i. Standard measurement 
The 1/10 dilution of ATP quantitative kit group has the highest light intensity and the 
average value of D1 & D2 is almost twice the one in D7& D8, which use half concentration 
of ATP. Though the value in 1/20 ATP quantitative kit dilution group is also very good, the 
biggest value is smaller than the one in 1/10 ATP quantitative kit dilution group. So in 
summary, the one in 1/10 ATP q kit dilution is the best choice for the ATP measurement in 
100μM group. 
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`  
Figure 6. A, B & C show the relationship between light intensity and time in 1/10, 1/20 & 1/50 
ATP q kit dilution group  
 
ii. ATP measurement 
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Figure 7. A shows in ATP capture assay, the relationship of concentration of ATP left in the upper 
solution with time; B & C they show the concentration of ATP diffused to the upper solution after 
interacting with gel 
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In the T2 & T2-ATP gel in capture assay in 100mM group, the light intensity coming 
from the T2 gel solution is weaker than the one in T2-ATP solution, which means there 
are more ATP left in solution of T2-ATP. It can indicate that T2 gel which doesn’t have 
ATP aptamer can capture or store ATP, while T2-ATP gel can’t. From the ATP release 
assay, the amount of ATP which diffuse to the upper solution after interaction with DNA 
hydrogel are still the same between T2 and T2-ATP gel. So from the 100μM ATP assay, 
we cannot find any evidence to show T2-ATP gel which contained ATP-aptamer can 
successfully capture ATP molecules, instead sometime the T2 gel can store or absorb 
some ATP molecules. 
 
3.4 Discussion  
From the results of these two experiments, we cannot find any evidence to support our 
expected conclusions that our ATP-binding aptamer-incorporated DNA hydrogel can 
successfully capture ATP. So after reviewing the whole process of this experiment, we find 
there is one point that has been ignored by us. If the captured ATP can still interact with 
Luciferase, we can’t figure out how much ATP was captured by DNA hydrogel even the 
fact whether our DNA hydrogel can capture ATP. So in order to solve this problem, we 
must separate the DNA hydrogel and Luciferase when we are doing measurement. So we 
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redesigned our current experiment. We form the DNA hydrogel in 1.5ml tube and after 
adding additional ATP solution and ATP quantitative buffer, shake the tube and ensure that 
the hydrogel is well-mixed with ATP and other solution. Then we periodically translate 
certain amount of solution from the tube to another new and clean tube. Add luciferase to 
the new tube and put it into luminometer to measure the light intensity. Luminometer is a 
equipment that can provide high performance for bioluminescent and chemiluminescent 
assay. It has a higher sensitivity than plate reader and it can detect even a very small change 
of substrate which make the gap like the one in figure 5 possible to be detected. If following 
this direction, it stands a good chance to get the amount of ATP captured by our hydrogel. 
3.5 Conclusion  
So far, our ATP-binding aptamer-incorporated DNA hydrogel does not show any obvious 
capacity of capturing ATP. 
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